Local Anesthesia Drugs Market
- 2026 年市場規模
- USD 5.3 Bn
- 2033 年預估規模
- USD 8.7 Bn
- 年複合成長率 CAGR
- 4.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Local Anesthesia Drugs Market, By Drug Type (Bupivacaine, Lidocaine, Benzocaine, Ropivacaine, Prilocaine, Chloroprocaine, and Others), By Mode Of Administration (Injectable and Surface Anesthetic), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Local anaesthesia involves numbing an area of the body using a type of medicine called a local anaesthetic. It is a type of pain control used during minor procedures to numb small area where the pain is likely to occur. The use of long-acting local anesthetic prolongs the anesthetic effect of regional anesthesia. Local anesthesia drugs can be used to treat painful conditions, prevent pain during a procedure or operation, or relieve pain after surgery. Local anesthetics are much safer to use, but have fewer side effects compared to general anesthetics.
Market Dynamics
Increasing use of local anesthesia drugs across the globe due to increase in number of surgeries and increasing use of local anesthetic for post-operative pain is expected to augment the growth of the global local anesthesia drugs market over the forecast period. For instance, according to the American Society of Plastic Surgeons, in 2020, over 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and around 2.3 million cosmetic surgical procedures were performed in the United States.
Moreover, in May 2021, the Food and Drug Administration (FDA) approved the first extended-release dual acting local anesthetic of bupivacaine and meloxicam for pain management.
Key features of the study
• This report provides in-depth analysis of the global local anesthesia drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021–2028), considering 2020 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global local anesthesia drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global local anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global local anesthesia drugs market.
Market Segmentation
• By Drug Type
o Bupivacaine
o Lidocaine
o Benzocaine
o Ropivacaine
o Prilocaine
o Chloroprocaine
o Others
• By Mode Of Administration
o Injectable
o Surface Anesthetic
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Septodont
o Pfizer Inc.
o Pacira BioSciences, Inc.
o Braun Melsulgen AG
o Glenmark Pharmaceutical Ltd.
o Fresenius SE & Co. KgaA
o Hikma Pharmaceuticals PLC
o Teva Pharmaceutical Industries Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Nasal Drug Delivery Mode, By Drug Type
Market Nasal Drug Delivery Mode, By Mode of Administration
Market Nasal Drug Delivery Mode, By Geography
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Increase in number of surgeries worldwide
Side effects of anesthetic drugs
Growing use of local anesthetic drugs
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product launch/Approvals
o PEST Analysis
o PORTER’s Analysis
o Merger and Acquisition Scenario
4. Local Anesthesia Drugs Market, By Drug Type, 2026 - 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Bupivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Lidocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Benzocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Ropivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Prilocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Chloroprocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Local Anesthesia Drugs Market, By Mode of Administration, 2026 - 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Surface Anesthetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Local Anesthesia Drugs Market, By Geography, 2026 - 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Countries
o U.S.
o Canada
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Countries
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Septodont
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pacira BioSciences, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Braun Melsulgen AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Glenmark Pharmaceutical Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Fresenius SE & Co. KgaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Analyst Views
8. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們